Universe Pharmaceuticals INC (NASDAQ:UPC – Get Free Report) saw a significant decrease in short interest in May. As of May 31st, there was short interest totalling 41,200 shares, a decrease of 59.4% from the May 15th total of 101,400 shares. Approximately 95.8% of the company’s shares are sold short. Based on an average daily volume of 345,300 shares, the short-interest ratio is presently 0.1 days.
Universe Pharmaceuticals Stock Up 2.3%
Shares of Universe Pharmaceuticals stock opened at $3.98 on Monday. Universe Pharmaceuticals has a one year low of $2.51 and a one year high of $2,592.00.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of Universe Pharmaceuticals from a “strong sell” rating to a “hold” rating in a research report on Saturday, May 24th.
About Universe Pharmaceuticals
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Recommended Stories
- Five stocks we like better than Universe Pharmaceuticals
- Utilities Stocks Explained – How and Why to Invest in Utilities
- RH Stock Rockets on Surprise Profit and Tariff Shift
- Why Invest in High-Yield Dividend Stocks?
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- The Role Economic Reports Play in a Successful Investment Strategy
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for Universe Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universe Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
